J. Christopher Naftzger, General Counsel and CCO at Arbutus Biopharma Corp (ABUS), sold 11,333 shares at $3.28 ($37K) on 2025-02-04, disclosed to the SEC on 2025-02-05.
Scheduled sale ($37k) by General Counsel and CCO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| UNIS | BUY | 2011-03-02 | $14K | — | Filing → |